EndeavorOTC for Attention Deficit Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital therapy called EndeavorOTC to assess its impact on attention and cognitive skills in university students. The goal is to determine if this digital tool can enhance focus and emotional health. Participants will use an app for 12 weeks, with one group starting immediately and another group waiting six weeks. It suits university students who own a smartphone or tablet and wish to improve their attention and cognitive functioning. As an unphased trial, this study provides a unique opportunity for students to potentially enhance their cognitive skills and emotional well-being through innovative digital therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this digital therapeutic is safe for university students?
Research shows that EndeavorOTC is a safe treatment for adults with ADHD. The FDA has approved this digital therapy for use without a prescription. In earlier studies, many participants experienced noticeable improvements in their ADHD symptoms. Specifically, 32.7% of participants saw their ADHD Rating Scale scores drop by at least 30%.
While EndeavorOTC is generally well-tolerated, it is not recommended for people with other psychiatric conditions in addition to ADHD. Thus, while the treatment is safe for many, those with more complex mental health issues should consult their healthcare providers. Overall, evidence supports that EndeavorOTC is a safe and effective way to improve attention and reduce ADHD symptoms in adults.12345Why are researchers excited about this trial?
EndeavorOTC is unique because it offers a non-pharmaceutical approach to managing Attention Deficit Disorder, utilizing a digital therapy platform instead of traditional medication like stimulants or non-stimulants. Unlike other treatments that often involve pills, EndeavorOTC delivers engaging video game-like experiences designed to target and improve cognitive functions directly related to attention. Researchers are excited about this treatment because it has the potential to provide a fun, side-effect-free option that can be easily integrated into daily life, making it a game-changer for those who prefer or require alternatives to medication.
What evidence suggests that EndeavorOTC is effective for Attention Deficit Disorder?
Research has shown that EndeavorOTC, a digital therapy tool, holds promise for improving attention deficit disorder symptoms. In earlier studies, 37% of users no longer showed signs of attention deficit, and 33% experienced significant improvements in their ADHD symptoms. Additionally, 83% of participants reported better focus after using EndeavorOTC for six weeks. Users noted increased productivity, with 78% feeling more productive and 73% experiencing a better quality of life. These results suggest that EndeavorOTC could effectively manage attention and thinking issues. Participants in this trial will receive either immediate or delayed access to EndeavorOTC to further evaluate its effectiveness.14678
Who Is on the Research Team?
Caitlin Stamatis, PhD
Principal Investigator
Akili Interactive Labs, Inc.
Are You a Good Fit for This Trial?
This study is for university students who may have attention issues or want to improve their cognitive functioning. Participants should be interested in trying a digital therapeutic called EndeavorOTC®.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 12-week access to EndeavorOTC, a digital therapeutic, to evaluate its impact on cognitive and emotional health
Follow-up
Participants are monitored for changes in cognitive functioning, academic outcomes, social functioning, attention, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- EndeavorOTC®
Trial Overview
The trial is testing the effects of a digital therapy app, EndeavorOTC®, on executive and cognitive functions in college students. It aims to see if this app can help with focus, memory, and other brain skills.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants receive 12-week access to EndeavorOTC 6-weeks after Group 1.
Participants receive immediate 12-week access to EndeavorOTC.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Akili Interactive Labs, Inc.
Lead Sponsor
Landmark College
Collaborator
Villa Maria College
Collaborator
Published Research Related to This Trial
Citations
Evidence
37% no longer exhibited an attention deficit · 33% had clinically meaningful improvements in ADHD symptoms · 61% reported clinically meaningful improvements in ...
STARS-ADHD Adolescent
Following treatment, participants in the study showed significant improvement on both the inattention subscale and total score of the ADHD-RS (p<0.0001 for both) ...
EndeavorOTC | A Digital Treatment for Adult ADHD
60% were better able to complete projects on time ; 78% reported increased productivity ; 54% were better able to keep track of important items such as their keys ...
EndeavorOTC
After 6-weeks of EndeavorOTC use, 83% of participants saw clinical improvements in their ability to focus after 6 weeks, 73% reported better quality of life ...
Real-time cognitive performance metrics derived from a digital ...
We aimed to derive a real-time measure of attention from AKL-T01 gameplay data and validate it against clinical outcomes. Trials of AKL-T01 ...
STARS-ADHD Adult Study
A prespecified responder analysis also showed that 32.7% of all participants in the study demonstrated at least a 30% reduction in total scores on the ADHD-RS.
June 14, 2024 Akili Interactive Labs, Inc. Bhupinder Singh ...
EndeavorOTC is not for persons who have a comorbid psychiatric condition in addition to. ADHD. When using this device it is recommended that ...
EndeavorRx® - ADHD Video Game Treatment for Kids | FDA ...
68% of parents reported improvement in ADHD-related impairments after two months of treatment. 2. 73% of children reported an improvement in their attention. 1.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.